ALMS
Alumis Inc.
$29.27
+2.00 (+7.33%)
At close · Jul 7
Market Cap
$3.73B
Shares
127,491,980
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-29 | Envudeucitinib Investor Call - AAD 2026 Phase 3 ONWARD Data | Event |
| 2026-03-09 | Leerink Global Healthcare Conference | Conference |
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-02-12 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Event |
| 2026-01-06 | Alumis Envudeucitinib ONWARD Phase 3 Plaque Psoriasis Trial Results | Event |
| 2025-11-12 | Stifel 2025 Healthcare Conference | Conference |
| 2025-11-11 | Guggenheim’s 2nd Annual Healthcare Innovation Conference | Conference |
| 2025-09-16 | Stifel 2025 Virtual Immunology & Inflammation Forum | Event |
| 2025-09-10 | Baird 2025 Global Healthcare Conference | Conference |
| 2025-09-09 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-09-08 | 23rd Morgan Stanley Annual Global Healthcare Conference | Conference |
| 2025-09-05 | 2025 Wells Fargo Healthcare Conference | Conference |
| 2025-09-03 | Cantor Global Healthcare Conference 2025 | Conference |
| 2025-06-04 | Jefferies Global Healthcare Conference | Conference |
Source: https://investors.alumis.com/